Completed PHASE2 INTERVENTIONAL 1-arm NCT00923897

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

Phase II Trial of Palliative Radiotherapy for Locally Advanced Hepatocellular Carcinoma and Hepatic Metastases

Sponsor: Princess Margaret Hospital, Canada

Conditions Hepatic Metastasis Hepatocellular Carcinoma

Updated 6 times since 2017 Last updated: Jun 14, 2019 Started: Feb 28, 2007 Primary completion: Sep 26, 2018 Completion: Sep 26, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00923897, this PHASE2 trial focuses on Hepatic Metastasis and Hepatocellular Carcinoma and remains completed. Sponsored by Princess Margaret Hospital, Canada, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jul 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Jul 2019 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Princess Margaret Hospital, Canada
University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada